SINT (SINTX Technologies) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is SINTX Technologies 3-Year Dividend Growth Rate?

SINTX Technologies's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

The historical rank and industry rank for SINTX Technologies's 3-Year Dividend Growth Rate or its related term are showing as below:

SINT's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 11.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

SINTX Technologies's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, SINTX Technologies's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of SINTX Technologies's 3-Year Dividend Growth Rate

For the Medical Devices subindustry, SINTX Technologies's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SINTX Technologies's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's 3-Year Dividend Growth Rate falls into.

SINTX Technologies 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

SINTX Technologies (NAS:SINT) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

SINTX Technologies's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	-2.164
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SINTX Technologies 3-Year Dividend Growth Rate Related Terms>

SINTX Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SINTX Technologies Inc (NAS:SINT) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

0A8S:UK

Address

1885 West 2100 South, Salt Lake City, UT, USA, 84119

Website

https://www.sintx.com

SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Executives

David W. Truetzel	director	C/O AMEDICA CORPORATION, 1885 WEST 2100 STREET, SALT LAKE CITY UT 84119
David Francis O'brien	officer: Chief Operating Officer	1885 WEST 2100 SOUTH, SALT LAKE CITY UT 84119
Ty Lombardi	officer: VP Finance	C/O AMEDICA CORPORATION, 1885 W 2100 SOUTH, SALT LAKE CITY UT 84119
Eric A Stookey	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Gordon Esplin	officer: Vice President, Finance	C/O AMEDICA CORPORATION, 1885 WEST 2100 SOUTH, SALT LAKE CITY UT 84119
Kevin Ontiveros	officer: See Remarks	C/O IMARX THERAPEUTICS INC, 1635 EAST 18TH STREET, TUCSON AZ 85719
Arthur Karl Kipke	10 percent owner	C/O AMEDICA CORPORATION, 1885 WEST 2100 STREET SOUTH, SALT LAKE CITY UT 84119
Jay M Moyes	director, officer: Chief Fnancial Officer
Vytas Rupinskas	officer: SVP, Marketing	C/O AMEDICA CORPORATION, 1885 WEST 1200 STREET, SALT LAKE CITY UT 84119
Eric K. Olson	director, officer: President and CEO	C/O AMEDICA CORPORATION, 1885 WEST 2100 STREET SOUTH, SALT LAKE CITY UT 84119
James P. Abraham	officer: SVP, Global Sales	C/O AMEDICA CORPORATION, 1885 WEST 1200 STREET, SALT LAKE CITY UT 84119
Christopher Whitfield	officer: Chief Commercial Officer	C/O AMEDICA CORPORATION, 1885 WEST 1200 STREET, SALT LAKE CITY UT 84119
Max Link	director	509 MADISON AVE 14TH FL, NEW YORK NY 10022
Kevin L Davis	officer: Chief Operating Officer	9149 SOUTH MONROE PLAZA WAY, SUITE B, SANDY UT 84070
Jeffrey S. White	director	C/O AMEDICA CORPORATION, 1885 WEST 2100 STREET SOUTH, SALT LAKE CITY UT 84119